SCHEMBL10791982

SCHEMBL10791982

NC(=O)/C(Br)=C(/Br)C(N)=O

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LDHA P00338 2/20 0.43
LDHB P07195 1/20 0.43
LMNA P02545 3/20 0.42
TDP1 Q9NUW8 2/20 0.42
ALDH1A1 P00352 2/20 0.42
OR51E2 Q9H255 1/20 0.42
ACHE P22303 1/20 0.39
BLM P54132 3/20 0.38
MEN1 O00255 1/20 0.38
KMT2A Q03164 1/20 0.38
PMP22 Q01453 2/20 0.36
ALOX15 P16050 1/20 0.36
CYP3A4 P08684 2/20 0.31
TSHR P16473 2/20 0.31
NFKB1 P19838 2/20 0.31
HPGD P15428 1/20 0.31
EHMT2 Q96KQ7 1/20 0.31
HSD17B10 Q99714 1/20 0.31
EHMT1 Q9H9B1 1/20 0.31
CYP1A2 P05177 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10791983 1.00 LDHA (0.43) LDHALDHBLMNATDP1ALDH1A1
SCHEMBL18383800 0.76
SCHEMBL332768 0.75
SCHEMBL2220156 0.70
SCHEMBL52275 0.68
SCHEMBL4475934 0.68 LMNA (0.62) LDHALDHBLMNATDP1ALDH1A1
Water SCHEMBL23118545 0.64
SCHEMBL1553741 0.64
Hydrochloric Acid SCHEMBL529581 0.64
Ammonia Solution, Strong SCHEMBL2783682 0.64

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 95 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4427149-A1 METHOD AND SYSTEM FOR PROCESSING DATABASE TRANSACTIONS IN A DISTRIBUTED ONLINE TRANSACTION PROCESSING (OLTP) DATABASE Huawei Technologies Co., Ltd. (CN) 2024-09-11 EP claimed
CN-114920963-B High-performance cyclic utilization branched dynamic crosslinking regenerated polyethylene resin and preparation method thereof 湖北工业大学 2024-07-26 CN claimed
CN-117616411-A Method and system for processing database transactions in a distributed online transaction processing (OLTP) database 华为技术有限公司 2024-02-27 CN claimed
WO-2023197932-A1 VIDEO FRAME ERROR HIDING METHOD AND APPARATUS, ELECTRONIC DEVICE, AND MEDIUM 维沃移动通信有限公司 2023-10-19 WO claimed
WO-2023109793-A1 METHOD AND SYSTEM FOR PROCESSING DATABASE TRANSACTIONS IN A DISTRIBUTED ONLINE TRANSACTION PROCESSING (OLTP) DATABASE HUAWEI TECHNOLOGIES CO., LTD. (CN) 2023-06-22 WO claimed
US-20230185795-A1 METHOD AND SYSTEM FOR PROCESSING DATABASE TRANSACTIONS IN A DISTRIBUTED ONLINE TRANSACTION PROCESSING (OLTP) DATABASE HUAWEI TECHNOLOGIES CO., LTD. (CN) 2023-06-15 US claimed
US-11669518-B1 Method and system for processing database transactions in a distributed online transaction processing (OLTP) database HUAWEI TECHNOLOGIES CO., LTD. (CN) 2023-06-06 US claimed
CN-114920963-A High-performance recycled branched dynamic cross-linked regenerated polyethylene resin and preparation method thereof 湖北工业大学 2022-08-19 CN claimed
CN-114255367-A Hyperspectral image classification method based on a small number of training samples 哈尔滨工程大学 2022-03-29 CN claimed
US-12585627-B1 Efficient database reads based on checkpoint avoidance ORACLE INTERNATIONAL CORPORATION (US) 2026-03-24 US disclosed
US-12585552-B2 Protection, recovery, and migration of databases-as-a-service (DBAAS) and/or serverless database management systems (DBMS) in cloud and multi-cloud COMMVAULT SYSTEMS, INC. (US) 2026-03-24 US disclosed
US-20260076942-A1 ARYL-IMINO TRYPTOPHAN DERIVATIVES Renovel Innovations, Inc. (US) 2026-03-19 US disclosed
CN-120724091-B Vehicle track prediction method and device 中电科新型智慧城市研究院有限公司 2026-01-06 CN disclosed
CN-120724091-A Vehicle track prediction method and device 中电科新型智慧城市研究院有限公司 2025-09-30 CN disclosed
CN-114040779-A Conjugates of cell binding molecules containing branched linkers and cytotoxic agents 杭州多禧生物科技有限公司 2022-02-11 CN disclosed
US-11229711-B2 Linkers for antibody-drug conjugates and related compounds, compositions, and methods of use Magenta Therapeutics, Inc. (US) 2022-01-25 US disclosed
CN-113195487-A 2, 3-diaminosuccinyl conjugate linkers 杭州多禧生物科技有限公司 2021-07-30 CN disclosed
US-20160367699-A1 NOVEL LINKERS FOR ANTIBODY-DRUG CONJUGATES AND RELATED COMPOUNDS, COMPOSITIONS, AND METHODS OF USE SENSEI BIOTHERAPEUTICS, INC. 2016-12-22 US disclosed
WO-2014197854-A1 NOVEL LINKERS FOR ANTIBODY-DRUG CONJUGATES AND RELATED COMPOUNDS, COMPOSITIONS, AND METHODS OF USE IGENICA BIOTHERAPEUTICS, INC. (US) 2014-12-11 WO disclosed
US-4680272-A Method for detecting molecules containing amine or thiol groups UNIVERSITY OF CALIFORNIA (US) 1987-07-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12585627-B1 Efficient database reads based on checkpoint avoidance CD274, PDCD1, PDCD1LG2 LDHA 2533/4885LDHB 2616/4885LMNA 2892/4885
US-11229711-B2 Linkers for antibody-drug conjugates and related compounds, compositions, and methods of use CLSPN, SDCBP, DCLRE1A LDHA 857/4885LDHB 501/4885LMNA 832/4885
US-20260076942-A1 ARYL-IMINO TRYPTOPHAN DERIVATIVES TPH1, IDO1, TPH2 LDHA 2000/4885LDHB 1448/4885LMNA 2321/4885
US-20160367699-A1 NOVEL LINKERS FOR ANTIBODY-DRUG CONJUGATES AND RELATED COMPOUNDS, COMPOSITIONS, AND METHODS OF USE SDCBP, DCLRE1A, BCR LDHA 949/4885LDHB 502/4885LMNA 1207/4885
US-12585552-B2 Protection, recovery, and migration of databases-as-a-service (DBAAS) and/or serverless database management systems (DBMS) in cloud and multi-cloud DCX, DDX41, TIAM1 LDHA 2332/4885LDHB 3268/4885LMNA 398/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.